 Genprex Inc NASDAQ: GNPX is a clinical-stage gene therapy organization that concentrates on the development of life-changing gene therapies to treat people with diabetes and cancer. The company announced that it had received FTD Fast Track Designation from the Food and Drug Administration for its REQORSA Immunogene therapy and went up by 130. 